Leukaemia’s evolution is already written right from the start, at the time of diagnosis
This discovery changes the view of the progression of leukaemia, opens the door to early diagnosis, and offers new treatment strategies.
Service News from Hematología
IDIBAPS and Fundació Clínic announce the 1st Estella Matutes Extraordinary Scholarship for research in lymphoid tumors
The call for the presentation of applications for the I Estella Matutes Extraordinary Scholarship is open from September 19th to November 30th.
Can Inflammatory Bowel Disease affect other parts of the body?
Despite being closely related to the digestive system, Inflammatory Bowel Disease (IBD) can affect other parts of the body such as the joints, skin...
A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clini...
Vulnerable people caring for vulnerable people
Carers from the Formació i Treball APROP job pool provide home care for people in the early stages of a bone marrow transplant. Between 2020 and 2...
Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood ca...
AEMPS authorises Hospital Clínic's CAR-T ARI-0001 for patients with acute lymphoblastic leukaemia
The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug...
Immuneel Therapeutics, Hospital Clínic de Barcelona & IDIBAPS Announce a Strategic collaboration & a License Agreement
Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with...
Coronavirus has a more serious impact on patients with haematological diseases
People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and...
Immunotherapy: an innovative and efficient tool in the battle against haematological tumours
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘imm...